US 12202895
LILRB4 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 12202895 (LILRB4 antibodies and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K47/6849